OBJECTIVE: To determine the prevalence of late complications in a large clinical sample of type 2 diabetic patients in Austria. METHODS: Data of all patients with type 2 diabetes entered into the database of the Forum for Quality Systems in Diabetes Care Austria (FQSD-A) between 1 January 1997 and 1 September 2007 were used for the analyses. RESULTS: Data from 23,641 persons with Type 2 Diabetes Mellitus were collected. Patients were 66.3 +/- 11.5 years old, with an average diabetes duration of 8.0 +/- 8.5 years. Prevalence of blindness, amputation, myocardial infarction or bypass, stroke and end stage renal failure was 0.9%, 2.3%, 12.2%, 8.7% and 0.8%, respectively. CONCLUSIONS: Prevalence of late diabetic complications in Austria is high compared with other European countries. The management of persons with Type 2 Diabetes should be further optimized to reduce the incidence of late complications of diabetes.
OBJECTIVE: To determine the prevalence of late complications in a large clinical sample of type 2 diabeticpatients in Austria. METHODS: Data of all patients with type 2 diabetes entered into the database of the Forum for Quality Systems in Diabetes Care Austria (FQSD-A) between 1 January 1997 and 1 September 2007 were used for the analyses. RESULTS: Data from 23,641 persons with Type 2 Diabetes Mellitus were collected. Patients were 66.3 +/- 11.5 years old, with an average diabetes duration of 8.0 +/- 8.5 years. Prevalence of blindness, amputation, myocardial infarction or bypass, stroke and end stage renal failure was 0.9%, 2.3%, 12.2%, 8.7% and 0.8%, respectively. CONCLUSIONS: Prevalence of late diabetic complications in Austria is high compared with other European countries. The management of persons with Type 2 Diabetes should be further optimized to reduce the incidence of late complications of diabetes.
Authors: I Rakovac; R J Gfrerer; W Habacher; S Seereiner; P Beck; A Risse; B Bauer; T R Pieber Journal: Diabetologia Date: 2004-07-22 Impact factor: 10.122
Authors: Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen Journal: N Engl J Med Date: 2003-01-30 Impact factor: 91.245
Authors: Maria Flamm; Sigrid Panisch; Henrike Winkler; Tim Johansson; Raimund Weitgasser; Andreas C Sönnichsen Journal: Wien Klin Wochenschr Date: 2012-08-08 Impact factor: 1.704
Authors: Maria Flamm; Henrike Winkler; Sigrid Panisch; Peter Kowatsch; Gert Klima; Bernhard Fürthauer; Raimund Weitgasser; Andreas C Sönnichsen Journal: Wien Klin Wochenschr Date: 2011-06-22 Impact factor: 1.704
Authors: Andreas C Sönnichsen; Henrike Winkler; Maria Flamm; Sigrid Panisch; Peter Kowatsch; Gert Klima; Bernhard Fürthauer; Raimund Weitgasser Journal: BMC Fam Pract Date: 2010-11-05 Impact factor: 2.497
Authors: Sigrid Panisch; Tim Johansson; Maria Flamm; Henrike Winkler; Raimund Weitgasser; Andreas C Sönnichsen Journal: Diabetol Metab Syndr Date: 2018-04-10 Impact factor: 3.320